These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malignancies. Bohannon L; Tang H; Page K; Ren Y; Jung SH; Artica A; Britt A; Islam P; Siamakpour-Reihani S; Giri V; Lew M; Kelly M; Choi T; Gasparetto C; Long G; Lopez R; Rizzieri D; Sarantopoulos S; Chao N; Horwitz M; Sung A Transplant Cell Ther; 2021 Aug; 27(8):669.e1-669.e8. PubMed ID: 33991725 [TBL] [Abstract][Full Text] [Related]
9. The impact of omidubicel on immune reconstitution and infections in cord blood transplant patients. De Sa H; Maziarz RT; Gandhi AP Expert Opin Biol Ther; 2024 Mar; 24(3):139-146. PubMed ID: 38481366 [TBL] [Abstract][Full Text] [Related]
10. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications. Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748 [TBL] [Abstract][Full Text] [Related]
11. [Umbilical cord blood as a source of stem cells]. Bojanić I; Golubić Cepulić B Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834 [TBL] [Abstract][Full Text] [Related]
12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
13. Comparison of clinical outcomes between unrelated single umbilical cord blood and "ex-vivo" T-cell depleted haploidentical transplantation in children with hematological malignancies. Gómez-Santos C; González-Vicent M; Molina B; Deltoro N; Herrero B; Ruiz J; Pérez-Martínez A; Diaz MA World J Pediatr; 2021 Dec; 17(6):609-618. PubMed ID: 34590210 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes. Cusatis RN; Tecca HR; D'Souza A; Shaw BE; Flynn KE Cancer; 2020 Jun; 126(11):2679-2686. PubMed ID: 32154926 [TBL] [Abstract][Full Text] [Related]
15. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults. Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537 [TBL] [Abstract][Full Text] [Related]
16. Randomized Controlled Trial of Isha Kriya versus Observation to Improve Quality of Life in Hematopoietic Cell Transplantation Recipients. Chopra M; Naik RR; Naik R; Sahni J; Bala K; Ahlawat J; Anand A; Singh C; Jandial A; Jain A; Prakash G; Khadwal A; Malhotra P; Lad DP Transplant Cell Ther; 2023 Aug; 29(8):530.e1-530.e5. PubMed ID: 37192731 [TBL] [Abstract][Full Text] [Related]
17. Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful. Shaw BE; Brazauskas R; Millard HR; Fonstad R; Flynn KE; Abernethy A; Vogel J; Petroske C; Mattila D; Drexler R; Lee SJ; Horowitz MM; Rizzo JD Cancer; 2017 Dec; 123(23):4687-4700. PubMed ID: 28817182 [TBL] [Abstract][Full Text] [Related]
18. Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402). Gooptu M; Kim HT; Howard A; Choi SW; Soiffer RJ; Antin JH; Ritz J; Cutler CS Biol Blood Marrow Transplant; 2019 Nov; 25(11):2143-2151. PubMed ID: 31271885 [TBL] [Abstract][Full Text] [Related]
19. Liberal Versus Restrictive Red Blood Cell Transfusion Thresholds in Hematopoietic Cell Transplantation: A Randomized, Open Label, Phase III, Noninferiority Trial. Tay J; Allan DS; Chatelain E; Coyle D; Elemary M; Fulford A; Petrcich W; Ramsay T; Walker I; Xenocostas A; Tinmouth A; Fergusson D J Clin Oncol; 2020 May; 38(13):1463-1473. PubMed ID: 32083994 [TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study. Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]